autoimmune regulator
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The AIRE gene provides instructions for making a protein called the autoimmune regulator. This protein is active primarily in the thymus, which is an organ located behind the breastbone that plays an important role in immune system function. The thymus prepares immune cells called T cells for their role in fighting infection; this process is called thymic education.
Video picks for GenesVideo library
Normal function
The AIRE gene provides instructions for making a protein called the autoimmune regulator. This protein is active primarily in the thymus, which is an organ located behind the breastbone that plays an important role in immune system function. The thymus prepares immune cells called T cells for their role in fighting infection; this process is called thymic education.
For a person to remain healthy, immune system cells such as T cells must be able to identify and destroy potentially harmful invaders (such as bacteria, fungi, and viruses) while sparing the body's normal tissues. The autoimmune regulator protein plays an important role in this process by helping T cells distinguish the body's own proteins from those of foreign invaders. When this system malfunctions, the immune system's ability to distinguish between the body's proteins and foreign invaders is impaired, and it may attack the body's own tissues and organs. This abnormal reaction is called autoimmunity. In the thymus, the autoimmune regulator protein destroys T cells that otherwise would cause autoimmune damage.
Conditions referring to this gene or chromosome
Other names
AIRE1
AIRE_HUMAN
APECED
APS1
APSI
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein
PGA1
Patient picks for Genes

Allergies, blood and immune system
What women need to know about autoimmune conditions
Autoimmune disorders are on the increase and around 75% of those affected are women. We examine the causes and look at treatment options and self-help measures to manage these debilitating conditions.
by Sally Turner

Digestive health
Autoimmune hepatitis
Autoimmune hepatitis is an uncommon cause of persistent liver inflammation (chronic hepatitis). The cause is not known. If left untreated, the inflammation causes 'scarring' of the liver (cirrhosis). However, with treatment, the outlook for people with this condition is very good. Treatment is usually with steroids and other medicines which suppress inflammation.
by Dr Rosalyn Adleman, MRCGP

Health news
Influencers are promoting dangerous peptides on social media – and regulators are struggling to keep up
Once confined to niche bodybuilding forums and hardcore gyms, unproven injectable peptides are now being openly marketed online to the average gym-goer by social media influencers – and regulators struggling to keep up. Across Instagram, TikTok or YouTube, unapproved and harmful peptide products are being promoted as shortcuts to fat loss, anti-ageing, health and recovery and muscle growth. Peptides actually occur naturally in our body. They regulate a variety of important functions, including metabolism, appetite, hormone production and tissue repair. Synthetic versions of peptides are also used in some medicines, which are legitimate and have been clinically proven. These include GLP-1s (which are used for weight loss and managing diabetes) and insulin. But a booming, parallel “grey market” now exists online for unapproved peptide compounds. These products are primarily being sold by so-called wellness brands and in influencer-led storefronts. Many of these products are marketed as cutting-edge solutions for optimising health and body enhancement. The problem is that many of these substances have not undergone full clinical safety evaluation and are not approved for human use. Many have also been found to be contaminated with other harmful ingredients. Unapproved injectable peptides therefore pose serious health risks. Some of the risks they may pose00092-0/abstract) include nausea, vomiting, abdominal pain, gastrointestinal issues, headaches and fatigue or weakness. Immune issues, as well as allergic reactions and infections have also been reported. Moreover, there’s a clear lack of rigorous human safety data. Yet these risks often aren’t disclosed by the people selling them.
by Luke Cox

Digestive health
What's autoimmune hepatitis and how does it differ from other forms?
You may have heard of hepatitis, but did you know that this liver condition can be both contagious and non-contagious? There are several causes of hepatitis, and different causes correspond to different types of the disease. Autoimmune hepatitis is an uncommon cause that may lead to serious complications.
by Amberley Davis
Related patient information and medicines

Patient information leaflet
Chronic lymphocytic leukaemia
Other common symptoms i... Some people with CLL also have an associated autoimmune disease Lymphocytes normally make antibodies to attack bacteria, viruses, and other 'germs'. In people with autoimmune diseases, the immune system also makes antibodies against part or parts of the body. Steroids also help to control autoimmune complications which.

Patient information leaflet
Can I take Chaga and Reishi together?
Diabetes These supplements can lower blood sugar levels; when combined with insulin or other dia... Autoimmune diseases (e.g., Lupus, MS, Rheumatoid Arthritis) Chaga can stimulate the immune system, which may worsen symptoms of autoimmune conditions or interfere with immunosuppressant medications. Bleeding disorders or upcoming surgery Both.

Patient information leaflet
Can I take Chaga and Maitake together?
Diabetes Both mushrooms can significantly lower blo... Autoimmune diseases (e.g., Lupus, MS, Rheumatoid Arthritis) Chaga can stimulate the immune system, which may worsen symptoms of autoimmune conditions or interfere with immunosuppressant medications. Bleeding disorders or upcoming surgery These mushrooms have anti-platelet effects and can thin.

Patient information leaflet
Myasthenia gravis
People with myasthenia gravis have a ... The muscles become easily tired and weak. What causes myasthenia gravis. Myasthenia gravis is an autoimmune disease. This means that the immune system The immune system (which normally protects the body from infections) mistakenly attacks itself. (Other autoimmune diseases include type 1 diabetes Type 1.

Patient information leaflet
Can I take Chaga and Shiitake together?
Diabetes Both mushrooms may significantly lower blood sugar levels, increasing the risk of hypoglycaemia (dangerously low blood sugar) if you are taking insulin or other diabetes medic... Autoimmune diseases (e.g., Lupus, MS, Rheumatoid Arthritis) Chaga can stimulate the immune system, which may worsen symptoms of autoimmune conditions or.

Patient information leaflet
Uveitis
Uveitis is a general term describing inflammation of the part of the eye called the uveal tract. ...wing: Autoimmune and inflammatory diseases Our immune systemIn people with autoimmune diseases, the immune system makes antibodies against the tissues of their body, causing damage and inflammation. Autoimmune diseases that are associated with.
Further reading and references
- autoimmune regulator; MedlinePlus, National Library of Medicine.
- Anderson MS, Su MA. AIRE expands: new roles in immune tolerance and beyond. Nat Rev Immunol. 2016 Apr;16(4):247-58. doi: 10.1038/nri.2016.9. Epub 2016 Mar 14.
- De Martino L, Capalbo D, Improda N, D'Elia F, Di Mase R, D'Assante R, D'Acunzo I, Pignata C, Salerno M. APECED: A Paradigm of Complex Interactions between Genetic Background and Susceptibility Factors. Front Immunol. 2013 Oct 23;4:331. doi: 10.3389/fimmu.2013.00331.
- De Martino L, Capalbo D, Improda N, Lorello P, Ungaro C, Di Mase R, Cirillo E, Pignata C, Salerno M. Novel Findings into AIRE Genetics and Functioning: Clinical Implications. Front Pediatr. 2016 Aug 22;4:86. doi: 10.3389/fped.2016.00086. eCollection 2016.
- Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C, Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB, Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016 Aug 18;1(13):e88782. doi: 10.1172/jci.insight.88782.
- Gallo V, Giardino G, Capalbo D, Palamaro L, Romano R, Santamaria F, Maio F, Salerno M, Vajro P, Pignata C. Alterations of the autoimmune regulator transcription factor and failure of central tolerance: APECED as a model. Expert Rev Clin Immunol. 2013 Jan;9(1):43-51. doi: 10.1586/eci.12.88.
- Kisand K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Strobel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med. 2010 Feb 15;207(2):299-308. doi: 10.1084/jem.20091669. Epub 2010 Feb 1.
- Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy. J Clin Immunol. 2015 Jul;35(5):463-78. doi: 10.1007/s10875-015-0176-y. Epub 2015 Jul 5.
- Laan M, Peterson P. The many faces of aire in central tolerance. Front Immunol. 2013 Oct 11;4:326. doi: 10.3389/fimmu.2013.00326.
- Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, Cobat A, Ouachee-Chardin M, Toulon A, Bustamante J, Al-Muhsen S, Al-Owain M, Arkwright PD, Costigan C, McConnell V, Cant AJ, Abinun M, Polak M, Bougneres PF, Kumararatne D, Marodi L, Nahum A, Roifman C, Blanche S, Fischer A, Bodemer C, Abel L, Lilic D, Casanova JL. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med. 2010 Feb 15;207(2):291-7. doi: 10.1084/jem.20091983. Epub 2010 Feb 1.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

